Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT) India, Germany sign Joint Declaration of Intent on environment conservation (See 'Corp Brief') IBC - If foreign decree from reciprocating territory remains substantially unsatisfied, and judgment debtor and his family exercise pervasive control over multiple business entities, decree holder is entitled to protection of its interest through appropriate security: SC LB (See 'Legal Desk') Advisor to PM reviews Development Initiatives at Belgaria and Karmatand Townships (See 'Corp Brief') Invest in R&D while fostering partnerships to become global enterprises: RM (See 'Corp Brief') SARFAESI - Attachment of entire subject property cannot be sustained in absence of material showing direct nexus between property & investors' funds involved in criminal proceedings: HC (See 'Legal Desk') Ministry of Coal Holds Preparatory Meeting for Special Campaign 6.0, Reaffirms Commitment to Cleanliness and Efficiency (See 'Corp Brief') PBPT - Per Section 2(26), initiating officer must establish that benami amount was either converted into another form or integrated into general business assets of beneficial owner beyond demarcation before attaching substitute properties: Tribunal (See 'Legal Desk') India must build Future-Ready Workforce for a Global Automotive Industry: Kumaraswamy (See 'Corp Brief') Union Minister to launch fisheries Infrastructure projects worth Rs 36.49 Crore (See 'Corp Brief') Nadda reviews Progress of Rural Health Training Centre, Najafgarh (See 'Corp Brief') IPR - If plaintiff holds registered trademark rights and shows prima facie prior adoption and use, defendant's use of identical mark for identical hospitality & restaurant services is sufficient to justify interim injunctive relief: HC (See 'Legal Desk') 4th Indo-German Environment Forum to be held in New Delhi (See 'Corp Brief') ICAR-IIOR to host Industry Interface to Accelerate Commercialization of Oilseed Technologies (See 'Corp Brief') A&C - Arbitral award immune to interference merely because alternative interpretation of facts or contractual terms exists; cannot be quashed where award is plausible, logical & free from patent illegality, perversity, or conflict with public policy: HC (See 'Legal Desk') Manohar Lal directs Fast-track Project Implementation & Strengthening of Swachhata (See 'Corp Brief') MSDE in collaboration with UP Govt organises PM-SETU Industry Conclave in Lucknow (See 'Corp Brief') MoS holds interaction with delegation of Armed Forces HQ Association (See 'Corp Brief') NBA disburses Rs 5.68 Crore in Benefit-Sharing Funds for Biodiversity Conservation (See 'Corp Brief') Commerce Secretary Rajesh Agrawal Leads 4th India-Argentina JTC Meeting (See 'Corp Brief') IBC - Sale certificate issued by liquidator under insolvency proceedings in respect of property sold by public auction is not compulsorily registrable: HC (See 'Legal Desk') CBN seizes 66.80 lakh psychotropic tablets in major inter-state pharmaceutical diversion case (See 'Corp Brief') Acquire knowledge, question injustice through constitutional means: RM tells youth (See 'Corp Brief') Empowering mother can enable early identification of disability in child: MoS (See 'Corp Brief') MoS lays Foundation Stone of PMGSY Roads Worth Rs 1,503 Crore in Jammu (See 'Corp Brief') Companies Act - Corporate name change is merely alteration of MoA that preserves company's continuous legal identity, rights, liabilities & obligations without creating a new entity or dissolving the old one: HC (See 'Legal Desk')

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES